Marinus Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MARINUS, and what generic alternatives to MARINUS drugs are available?
MARINUS has one approved drug.
There are eight US patents protecting MARINUS drugs.
There are forty-three patent family members on MARINUS drugs in fifteen countries.
Summary for Marinus
| International Patents: | 43 |
| US Patents: | 8 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Marinus
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Marinus | ZTALMY | ganaxolone | SUSPENSION;ORAL | 215904-001 | Jun 1, 2022 | RX | Yes | Yes | 8,022,054 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Marinus | ZTALMY | ganaxolone | SUSPENSION;ORAL | 215904-001 | Jun 1, 2022 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
| Marinus | ZTALMY | ganaxolone | SUSPENSION;ORAL | 215904-001 | Jun 1, 2022 | RX | Yes | Yes | 9,029,355 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Marinus | ZTALMY | ganaxolone | SUSPENSION;ORAL | 215904-001 | Jun 1, 2022 | RX | Yes | Yes | 8,367,651 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Marinus Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2018031748 | ⤷ Subscribe |
| Canada | 3032686 | ⤷ Subscribe |
| Spain | 2812250 | ⤷ Subscribe |
| European Patent Office | 3586845 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
